Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the Federal Food and Drug Administration to take action against "bad actors" selling counterfeit weight loss drugs.

Pharmaceutical giant Eli Lilly announced Wednesday that it plans to invest roughly $27 billion in United States manufacturing — more than doubling its investment over the past five years.

The Indianapolis Airport Authority announced this week that starting next May, it will offer nonstop service between Indianapolis and Dublin, Ireland.

Eli Lilly announced Wednesday it will invest another $4.5 billion into a new facility at the state’s controversial LEAP District in central Indiana.

Bill Gates visited Indiana University School of Medicine to learn about Alzheimer's research.

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug. The Food and Drug Administration approved Zepbound on Wednesday. The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds. It is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of Ozempic. Short supply and high costs have limited access to both medications. The FDA approved the new drug for people considered obese or for those who are overweight and have a weight-related health condition.

Indiana is one of two states that doesn’t allow DACA recipients access to in-state college tuition. Eli Lilly wants to bridge that gap for the state’s immigrant population.